Tadalafil for the Treatment of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Tadalafil for the Treatment of Pulmonary Arterial Hypertension

Published:2012-08 Issue:8 Volume:60 Page:768-774
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Oudiz Ronald J.,Brundage Bruce H.,Galiè Nazzareno,Ghofrani Hossein Ardeschir,Simonneau Gerald,Botros Fady T.,Chan Melanie,Beardsworth Anthony,Barst Robyn J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Development and pathology of pulmonary hypertension;Tuder;J Am Coll Cardiol,2009

2. Pulmonary arterial hypertension;Chin;J Am Coll Cardiol,2008

3. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension;Galiè;Eur Heart J,2009

4. Tadalafil therapy for pulmonary arterial hypertension;Galiè;Circulation,2009

5. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase;European Respiratory Review;2024-01-31

2. Hemoptysis Secondary to Anomalous Origin of Right Pulmonary Artery From Ascending Aorta in a Young Male: A Case Report;Cureus;2024-01-04

3. Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension;Advances in Therapy;2023-12-06

4. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives;Pharmaceuticals;2023-09-06

5. Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs;Pharmaceutics;2023-05-24